The Stevanato Group began 71 years ago by crafting specialty bottles for perfume and wine. A Covid-19 vaccine, which likely will have to be administered in two separate injections, will require billions of additional vials. Stevanato expects the pandemic to drive up demand for its glass vials by 20% over the next two years. “They had the prize that everyone wanted.”Vaccines face much tougher regulatory barriers than most other medicines and need to be stored in sterile glass vials and syringes, says Verkleeren of Corning. Spinning a sleek, Stevanato-made insulin pen between his fingers during an interview via video, Franco spells out a future in which his family firm expands into more complex products.

Source: The North Africa Journal September 03, 2020 13:52 UTC